Experts
have hope for an Alzheimer’s drug to be developed by 2025
Experts believe that some form of a new
Alzheimer’s drug will be developed by 2025, despite negative results of
recent Alzheimer’s disease clinical trials. Leading scientists believe
there is still great hope for novel therapies in the relative short term,
most likely pilot versions that will need to be upgraded.
Register
today for the 2017 Alzheimer’s Association Advocacy Forum
The relentless efforts of advocates of the
Alzheimer’s Association and the Alzheimer's Impact Movement, our
sister organization, have resulted in historic Alzheimer’s research
funding increases at the National Institutes of Health and greater
access to care and support services. But with a new administration
and a new Congress on the way, there’s more critical work to be done.
Join us at the 2017 Alzheimer’s Association Advocacy Forum March
27-29 to learn about the global and national impact of Alzheimer’s and
how to deliver our powerful messages to elected officials.
Developed by Alzheimer’s Australia, this hand-out sets forth appropriate language guidelines for talking about dementia, including language for talking about: People with dementia
Carers, families, etc.
People with dementia under 65
Behavioural and psychological symptom of dementia
People with dementia in research
The hand-out also provides a handy chart listing preferred terms, and terms that should not be used.